According to Hanmi Pharmaceutical
's latest financial reports the company has $26.67 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $17.06 M | 22.08% |
2021-12-31 | $13.97 M | 1.05% |
2020-12-31 | $13.83 M | -6.53% |
2019-12-31 | $14.79 M | -38.5% |
2018-12-31 | $24.05 M | -33.14% |
2017-12-31 | $35.98 M | -57.7% |
2016-12-31 | $85.06 M | 5.93% |
2015-12-31 | $80.3 M | 298.96% |
2014-12-31 | $20.12 M | 230.25% |
2013-12-31 | $6.09 M | -58.05% |
2012-12-31 | $14.52 M | 108.38% |
2011-12-31 | $6.97 M | -69.15% |
2010-12-31 | $22.59 M | 4.37% |
2009-12-31 | $21.65 M | -29.35% |
2008-12-31 | $30.64 M | 55.68% |
2007-12-31 | $19.68 M |